Jeong-Yeon Seon

Jeong-Yeon Seon

Auto-generated profile, based on publicly available information

Jeong-Yeon Seon

Department of Preventive Medicine, School of Medicine, Kyung Hee University, Seoul, Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Risk Management and Healthcare Policy
Verified
Journal Article
Open access
PDF file
SJSu Yeon Jang
Su Yeon Jang
JSJeong-Yeon Seon
Jeong-Yeon Seon
SYSeok-Jun Yoon
Seok-Jun Yoon
SPSo-Youn Park
So-Youn Park
SLSeungheon Lee
Seungheon Lee
Oh In-HwanOh In-Hwan
Oh In-Hwan
Purpose: No previous investigations of coronavirus disease 2019 (COVID-19) have estimated medical expenses, length of stay, or factors influencing them using administrative datasets. This study aims to fill this research gap for the Republic of Korea, which has over 10,000 confirmed COVID-19 cases. Patients and Methods: Using the nationwide health insurance claims data of 7590 confirmed COVID-19 patients, we estimated average medical expenses and inpatient days per patient, and performed multivariate negative binomial, and gamma regressions to determine influencing factors for higher outcomes. Results: According to the results, COVID-19 patients with history of ICU admission, chest CT imaging, lopinavir/ritonavir and hydroxychloroquine use stayed longer in the hospital and spent more on medical expenses, and anti-hypertensive drugs were insignificantly associated with the outcomes. Female patients stayed longer in the hospital in the over 65 age group but spent less in medical expenses that the 20– 39 group. In the 40– 69 age group, patients with health insurance stayed longer in the hospital and spent more on medical expenses than those aged over 65 years. Comorbidities did not affect outcomes in most age groups. Conclusion: In summary, contrary to popular beliefs, medical expenses and length of hospitalization were mostly influenced by age, and not by comorbidities, anti-viral, or anti-hypertensive drugs. Thus, responses should focus on infection prevention and control rather than clinical countermeasures.

1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SJSu Yeon Jang
Su Yeon Jang
JSJeong Yeon Seon
Jeong Yeon Seon
Oh In-HwanOh In-Hwan
Oh In-Hwan
Jang SY, et al. J Korean Med Sci. 2020 Aug;35(35):e290. https://doi.org/10.3346/jkms.2020.35.e290

14 October 2021 in Epidemiology and Psychiatric Sciences
Verified
Journal Article
Open access
PDF file
JSJeon-Yeon Seon
Jeon-Yeon Seon
SKSunjea Kim
Sunjea Kim
Minha HongMinha Hong
Minha Hong
MLMin Kyoung Lim
Min Kyoung Lim
IOIn Hwan Oh
In Hwan Oh
Aims: Patients with mental illness are vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection because of behavioural changes associated with cognitive deterioration, especially without their caregivers. While studies have reported that SARS-CoV-2 infection risk and severe clinical outcomes are high among patients with mental illness, there is a lack of quantitative research supporting this claim. This study investigates if SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19)-related death are higher in patients with mental illness than among those without a mental disorder. Methods: A cohort study was conducted using the COVID-19 database of the National Health Insurance Service in South Korea. A total of 123 480 patients aged ⩾20 years who visited a hospital between 1 January 2020 and 30 May 2020 were analysed. Mental disorder diagnoses and types were determined based on 2019 medical records, and a multivariate logistic regression model was used to calculate the odds ratios (ORs) for SARS-CoV-2 infection and deaths. Results: The ORs for SARS-CoV-2 infection (OR 1.58; 95% CI 1.45–1.71) and COVID-19-related death (OR 2.18; 95% CI 1.57–3.04) were high among patients with mental illness. The OR of SARS-CoV-2 infection was higher among patients with severe mental illness (OR 2.60; 95% CI 2.21–3.06), dementia (OR 1.90; 95% CI 1.62–2.22) and substance use disorder (OR 4.98, 95% CI 3.60–6.88). The OR for COVID-19-related death was high among patients with severe mental illness (OR 3.53; 95% CI 1.82–6.83) and dementia (OR 2.12; 95% CI 1.39–3.22). Conclusions: Patients with mental illness are at high risk for SARS-CoV-2 infection and COVID-19-related death. Behavioural changes associated with cognitive deterioration and long-term care facility residence increase SARS-CoV-2 infection risk, and severe medical conditions and delayed treatment increase the COVID-19-related mortality risk in patients with mental illness. Patients with mental illness are a priority target population for COVID-19 prevention and treatment, and it is important to plan prevention measures that address their needs.

1 January 2021 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SJSu Yeon Jang
Su Yeon Jang
JSJeong-Yeon Seon
Jeong-Yeon Seon
BEBaik-Lin Eun
Baik-Lin Eun
SKSeong-Beom Koh
Seong-Beom Koh
JYJin-Hong Yoo
Jin-Hong Yoo
SCSung-Goo Chang
Sung-Goo Chang
Jang SY, et al. J Korean Med Sci. 2021 May;36(18):e132. https://doi.org/10.3346/jkms.2021.36.e132

27 June 2022 in International Journal of Health Policy and Management
Verified
Journal Article
Open access
WJWoo-Hwi JEON
Woo-Hwi JEON
Oh In-HwanOh In-Hwan
Oh In-Hwan
JSJeong-Yeon Seon
Jeong-Yeon Seon
JKJin-Nam Kim
Jin-Nam Kim
SPSo-Youn Park
So-Youn Park
Background: With the delayed eradication of coronavirus disease 2019 (COVID-19), people with disabilities, a socially vulnerable class of individuals, face aggravated hardships caused by a pause in support services and lack of care due to stricter social distancing policies combined with the challenges of their disabilities. Given this background, we aim to investigate COVID-19 infection and mortality rates among people with disabilities, who face heightened physical and mental health threats amidst the COVID-19 pandemic. Methods: Gender, age, health insurance premiums, the Charlson Comorbidity Index (CCI), the severity of the disability, and the type of disability were compared among people with disabilities who had been infected with or died from COVID-19 using the nationally representative National Health Insurance Service (NHIS)-COVID-19 database (DB). Results: We found that the COVID-19 infection rate was higher among those with low income, those with severe disability, and those with "other" disabilities (ie, speech disabilities, hepatic dysfunction, respiratory dysfunction, facial disfigurement, intestinal fistular/urinary disability, epilepsy, intellectual disability, autistic disorder, and mental disorders). The mortality rate was markedly higher (ie, 15.90 times higher, odds ratio [OR]: 15.90, 95% confidence interval [CI]: 6.16 - 41.06) among people aged 80 years or older as compared with those aged 60 years or younger. The odds for mortality were 2.49 times higher (OR: 2.49, 95% CI: 1.33 - 4.64) among people with severe disabilities as compared with mild disabilities. Conclusion: Among people with disabilities, we found that COVID-19 infection rates differed according to income level, severity of the disability, and disability type, while the COVID-19 mortality rates differed according to age and severity of the disability.

1 January 2021 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JSJeong-Yeon Seon
Jeong-Yeon Seon
WJWoo-Hwi JEON
Woo-Hwi JEON
SBSuk-Chul Bae
Suk-Chul Bae
BEBaik-Lin Eun
Baik-Lin Eun
JCJi-Tae Choung
Ji-Tae Choung
Oh In-HwanOh In-Hwan
Oh In-Hwan
Seon JY, et al. J Korean Med Sci. 2021 May;36(20):e148. https://doi.org/10.3346/jkms.2021.36.e148